SU507322A1 - Regulator of hormonal exchange of skin - Google Patents

Regulator of hormonal exchange of skin

Info

Publication number
SU507322A1
SU507322A1 SU1937601A SU1937601A SU507322A1 SU 507322 A1 SU507322 A1 SU 507322A1 SU 1937601 A SU1937601 A SU 1937601A SU 1937601 A SU1937601 A SU 1937601A SU 507322 A1 SU507322 A1 SU 507322A1
Authority
SU
USSR - Soviet Union
Prior art keywords
skin
hormonal
regulator
exchange
sodium
Prior art date
Application number
SU1937601A
Other languages
Russian (ru)
Inventor
Антонина Федоровна Ахабадзе
Нелли Борисовна Высоцкая
Алла Григорьевна Стренковская
Original Assignee
Московский Научно-Исследовательский Институт Косметологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский Научно-Исследовательский Институт Косметологии filed Critical Московский Научно-Исследовательский Институт Косметологии
Priority to SU1937601A priority Critical patent/SU507322A1/en
Application granted granted Critical
Publication of SU507322A1 publication Critical patent/SU507322A1/en

Links

Description

1one

Изобретение относитс  к косметопогчи.This invention relates to cosmetics.

Дл  соадани  косметических средс- в широко примен ютс  биологически-активные вещестаа - витамины, гормоны, растительные биостимул торы, аминокислоты и т.п.Biologically active substances such as vitamins, hormones, vegetable biostimulants, amino acids, etc. are widely used for cosmetic cosmetics.

Целью изобретени   вл етс  применение оксибутирата натри  в качестве регул тора гормонального обмена кожи в косметьвеских средствах.The aim of the invention is the use of sodium hydroxybutyrate as a regulator of skin hormonal metabolism in cosmetic media.

СНссибутират натри  - натриева  соль гам маоксимасл нсА кислоты йрёдставл ёт собой белый с кремс эым оттенком кристарпичесхий со слабым специфическим запахом , который легко растворим в воде и фиэиологическс л pactBc e, растворим в спнр те, гигроскопи шн,Sodium ssibutirate - sodium salt gammaoxy acid nsA acid is represented by a white with a creamy tinge of crystal with a low specific odor, which is easily soluble in water and pactBc e is soluble in spirits, hygroscopic acid,

Раствор оксибутирата натри  выаерживает стерилизацию кип чением в течение ЗОма Выпускаетс  в виде порошка или 2О%-ного раствора в ампулах.Sodium hydroxybutyrate solution retards sterilization by boiling for 3 hours. Produced as a powder or a 2 O% solution in ampoules.

Оксибутират натри  относитс  к группе тканевых метаболитов: он изме-г ет уровень катехоламинс® мозга, стимулирующе де 1ствует на окислительные процессы мозга, оказывает положительный эффект на окислительныеSodium oxybutyrate belongs to the group of tissue metabolites: it alters the level of catecholamine® of the brain, stimulates the oxidative processes of the brain, has a positive effect on the oxidative

22

процессы в тка  х. Кроме этих свойств вы- йвпенгг новые свойства препарата, он вли ет ка обменнь.а процессы кожи.processes in x. In addition to these properties of vypypeng new properties of the drug, it affects the exchange of skin processes.

Оксибутират натри  оказывает положитель ное действие на процессы гормонального обмена кожи, снижг.ет интенсчвност синтеза и накопление холестерина, выпывает кг.чественные и колиЧествинньге изменени  содер- жини  стерогдных тормонов-эстрбгенов и андрогенов , т.е. увеличение уровн  эстрилта и эcтpa aoлa выравнивание vJИHтeзa 17-кето- стероидов, кэ оказывает при этом отрицательного вли ни  на организм в целом.Sodium oxybutyrate has a positive effect on the processes of hormonal metabolism of the skin, reduces the intensity of synthesis and accumulation of cholesterol, drops out of kg. Of high-quality and quantitative changes in the content of sterogdormon-estrbgens and androgens, i.e. an increase in estrilt and ectol aal levels the alignment of 17-keto-steroids VJHYTES, ke has a negative effect on the organism as a whole.

Явл  сь г звестным биологически-активным веществом, окскбутираг натри  примеKsnoT в качестве биoлoги ecки-активного компонента дл  введени  t различные косметические средства (кремы, эмульсии, .:осьон1-), предназначенные дл  лечэни  и профилактики косметических недостатков ев званных с нарушени ми гормонального баланса кожи: , старени  кожи, себор и, себорейного выпадаДйЯ волос, угревой сыпи и т.д. 34Well known as a biologically active substance, sodium oxcartilage is used as a biologically active ingredient for administering various cosmetics (creams, emulsions, otionon1-) for the treatment and prevention of cosmetic deficiencies caused by hormonal imbalance skin: aging of skin, seborrhea, seborrhoeic hair loss, acne, etc. 34

Крем с оксибутиратом натри  примен: ютотечность век, отмечают свежесть лица,Cream with sodium hydroxybutyrate is applied: yuthotechnost eyelids, note the freshness of the face,

Е зиде маски на лицо ежедневно в течениеулучшение тургора и более спокойное общее:E zide masks on the face daily for an improvement in turgor and a more relaxed general:

мес ца. Продолжительность маски 20-30 мин. состо ние.month The duration of the mask is 20-30 minutes. condition.

Claims (1)

Пефеносимость крема хороша . Наблюдени  Формула изобретен и  Cream portability is good. Observations Formula invented and iJoK-азывают, что после п ти процедур отмеча-;л Йрименёние оксибутирата натри  в качеют изменение цвета Ложи. Кожа становитс стве регул тора гормонального обмена коболее светлой, розовой, исчезает пастозность,;жи.в косметических средствах.iJoK-they say that after five procedures, sodium oxybutyrate is noted to change the color of the Lodge. The skin becomes a regulator of hormonal metabolism more pale, pink, pastoznost disappears, and in cosmetics. 507322 507322
SU1937601A 1973-07-26 1973-07-26 Regulator of hormonal exchange of skin SU507322A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU1937601A SU507322A1 (en) 1973-07-26 1973-07-26 Regulator of hormonal exchange of skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU1937601A SU507322A1 (en) 1973-07-26 1973-07-26 Regulator of hormonal exchange of skin

Publications (1)

Publication Number Publication Date
SU507322A1 true SU507322A1 (en) 1976-03-25

Family

ID=20558131

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1937601A SU507322A1 (en) 1973-07-26 1973-07-26 Regulator of hormonal exchange of skin

Country Status (1)

Country Link
SU (1) SU507322A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173467A (en) * 1966-04-12 1969-12-10 United Aircraft Corp Gas Discharge Structures for Gas Turbine Engines
GB2511941A (en) * 2013-03-12 2014-09-17 Tdeltas Ltd Compound for use in protecting skin
US9211275B2 (en) 2008-01-04 2015-12-15 Isis Innovation Ltd. Ketone bodies and ketone body esters as blood lipid lowering agents
US9579302B2 (en) 2012-11-05 2017-02-28 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
US10051880B2 (en) 2008-08-21 2018-08-21 Oxford University Innovation Limited Hydroxybutyrate ester and medical use thereof
US10660958B2 (en) 2010-02-22 2020-05-26 Tdeltas Limited Nutritional composition
US11230722B2 (en) 2003-06-03 2022-01-25 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
US11566268B2 (en) 2013-03-14 2023-01-31 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173467A (en) * 1966-04-12 1969-12-10 United Aircraft Corp Gas Discharge Structures for Gas Turbine Engines
US11230722B2 (en) 2003-06-03 2022-01-25 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
US11311509B2 (en) 2008-01-04 2022-04-26 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US9211275B2 (en) 2008-01-04 2015-12-15 Isis Innovation Ltd. Ketone bodies and ketone body esters as blood lipid lowering agents
US10154982B2 (en) 2008-01-04 2018-12-18 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US10051880B2 (en) 2008-08-21 2018-08-21 Oxford University Innovation Limited Hydroxybutyrate ester and medical use thereof
US10660958B2 (en) 2010-02-22 2020-05-26 Tdeltas Limited Nutritional composition
US11571479B2 (en) 2010-02-22 2023-02-07 Tdeltas Nutritional composition
US11234953B2 (en) 2012-11-05 2022-02-01 Tdeltas Limited Ketone bodies to protect tissues from damage by ionizing radiation
US10478415B2 (en) 2012-11-05 2019-11-19 Tdeltas Limited Ketone bodies to protect tissues from damage by ionizing radiation
US9579302B2 (en) 2012-11-05 2017-02-28 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
US10821062B2 (en) 2013-03-12 2020-11-03 Tdeltas Limited Compound for use in protecting skin
GB2511941B (en) * 2013-03-12 2016-03-30 Tdeltas Ltd Compound for use in protecting skin
WO2014139599A1 (en) * 2013-03-12 2014-09-18 Tdeltas Limited Compound for use in protecting skin
GB2511941A (en) * 2013-03-12 2014-09-17 Tdeltas Ltd Compound for use in protecting skin
US11566268B2 (en) 2013-03-14 2023-01-31 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Similar Documents

Publication Publication Date Title
RU2381022C2 (en) External skin preparation
US9399030B2 (en) Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same
RU2764769C2 (en) Products for external application with a two-phase system
SU507322A1 (en) Regulator of hormonal exchange of skin
US4054649A (en) Therapeutic compositions and the treatment of lesions of connective tissue
JP2004339142A (en) Skin cosmetic
JPH02292215A (en) External remedy and its usage
US7955610B2 (en) Antimicrobial composition for topical application and a method thereof
JP2004517857A (en) Whitening agent containing arbutin and glucosidase as active ingredients
JP3881411B2 (en) Composition suitable for external use
JP2001220340A (en) Skin preparation for external use for preventing aging
JP3403780B2 (en) Cosmetics
CN111529460B (en) Mask composition, mask and preparation method of mask
JPS59130207A (en) Corium and hair growth promoting cosmetic composition
RU2029544C1 (en) Lotion for face skin
JPH01207225A (en) Cosmetic for hair
RU2028796C1 (en) Cream-mask
RU2026668C1 (en) Cream for dry wilting face skin care
JPH08133959A (en) Skin cosmetic
GB2159053A (en) Hair lotions
JPH0971520A (en) Skin cosmetic
RU95102690A (en) Cosmetic mask and method of its using
JPH02221213A (en) Skin cosmetic
JP2013082631A (en) Composition for promotion of noninvasive removal of skin pigment
SU912168A1 (en) Aqueous-alcoholic water for fatty hairs